Ganciclovir-resistant cytomegalovirus infection in transplanted patients: utility of drug monitoring
Cytomegalovirus (CMV) infection remains a major cause of morbidity, graft failure, and death in kidn...
ABSTRACT: BACKGROUND: Valganciclovir, the oral prodrug of ganciclovir, has been demonstrated equival...
This paper presents three cases of immunocompromised patients for whom therapeutic drug monitoring (...
Cytomegalovirus (CMV) infection is a common complication following solid organ transplantation that ...
Cytomegalovirus (CMV) breakthrough despite therapy with ganciclovir remains a problem, particularly ...
Infection with cytomegalovirus (CMV) with resistance to ganciclovir (GCV) is a therapeutic challenge...
Cytomegalovirus (CMV) is one of the most common opportunistic infections after transplantation. To p...
The resistance of cytomegalovirus (CMV) to ganciclovir or valganciclovir is a factor in therapeutic ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background: the widespread use of prophylactic ganciclovir and anti-lymphocyte/thymocyte therapies a...
Ganciclovir (GCV) resistant cytomegalovirus (CMV) infection is a common problem among solid organ tr...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Ganciclovir (GCV) is the first t...
Cytomegalovirus (CMV) infection is themost common infectious complication following solid organ tran...
Cytomegalovirus (CMV) is a main cause of severe morbidity and mortality in immunocompromised patient...
Ganciclovir (GCV) is the first therapeutic choice for prevention and treatment of active cytomegalov...
Cytomegalovirus (CMV) infection remains a major cause of morbidity, graft failure, and death in kidn...
ABSTRACT: BACKGROUND: Valganciclovir, the oral prodrug of ganciclovir, has been demonstrated equival...
This paper presents three cases of immunocompromised patients for whom therapeutic drug monitoring (...
Cytomegalovirus (CMV) infection is a common complication following solid organ transplantation that ...
Cytomegalovirus (CMV) breakthrough despite therapy with ganciclovir remains a problem, particularly ...
Infection with cytomegalovirus (CMV) with resistance to ganciclovir (GCV) is a therapeutic challenge...
Cytomegalovirus (CMV) is one of the most common opportunistic infections after transplantation. To p...
The resistance of cytomegalovirus (CMV) to ganciclovir or valganciclovir is a factor in therapeutic ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background: the widespread use of prophylactic ganciclovir and anti-lymphocyte/thymocyte therapies a...
Ganciclovir (GCV) resistant cytomegalovirus (CMV) infection is a common problem among solid organ tr...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Ganciclovir (GCV) is the first t...
Cytomegalovirus (CMV) infection is themost common infectious complication following solid organ tran...
Cytomegalovirus (CMV) is a main cause of severe morbidity and mortality in immunocompromised patient...
Ganciclovir (GCV) is the first therapeutic choice for prevention and treatment of active cytomegalov...
Cytomegalovirus (CMV) infection remains a major cause of morbidity, graft failure, and death in kidn...
ABSTRACT: BACKGROUND: Valganciclovir, the oral prodrug of ganciclovir, has been demonstrated equival...
This paper presents three cases of immunocompromised patients for whom therapeutic drug monitoring (...
DOI
Add to ORKG